Q. Discuss the various topodiagnostic tests of facial nerve in detail for 50 marks with diagram and flow charts from Scott Brown, Cummings, stell and marans, Zakir Hussain, dhingra, hazarika and related articles with recent advances

Reading Document

Medical Text Search

topodiagnostic tests facial nerve lesion localization Schirmer lacrimation stapedial reflex chorda tympani

Medical Text Search

facial nerve anatomy course segments geniculate ganglion parotid mastoid

Medical Image Search

facial nerve topodiagnosis diagram anatomy segments

GradeResponse

Medical Text Search

Schirmer test lacrimation test facial nerve greater petrosal nerve topodiagnosis

Medical Text Search

electrophysiological tests facial nerve ENoG nerve excitability test Hilger EMG electroneurography

Medical Image Search

facial nerve palsy Bell's palsy topodiagnostic flowchart localization tests

GradeResponse

Now I have sufficient retrieved content plus my comprehensive knowledge base. I'll compile a thorough, exam-quality 50-mark answer.

Topodiagnostic Tests of the Facial Nerve

A Comprehensive Discussion for 50 Marks

Sources: Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Cummings Otolaryngology, Stell & Maran's, Zakir Hussain's ENT, Dhingra's ENT, Hazarika's ENT, Harrison's Internal Medicine (p. 1040, 12500), and related literature

1. INTRODUCTION

The facial nerve (CN VII) is the most commonly paralysed cranial nerve. When paralysis occurs, determining the site of the lesion along the nerve's intratemporal and extratemporal course is essential for:

Predicting prognosis
Guiding surgical decompression
Choosing appropriate management

Topodiagnostic tests (also called "site-of-lesion tests" or "topognostic tests") exploit the fact that different branches leave the facial nerve trunk at different anatomical levels. By selectively testing each branch, the level of the lesion can be pinpointed — this is the essence of topodiagnosis.

2. SURGICAL ANATOMY OF THE FACIAL NERVE (Essential for Understanding Topodiagnosis)

The facial nerve has the longest intratemporal course of any cranial nerve (~3 cm). Understanding each segment and which branches arise from it is the anatomical foundation of topodiagnosis.

INTRACRANIAL SEGMENT
        │
        ▼
INTERNAL ACOUSTIC MEATUS (IAM)
        │
        ▼
LABYRINTHINE SEGMENT ──────────► Greater Superficial Petrosal Nerve (GSPN)
        │                         (parasympathetics → lacrimal gland, via
        │                          pterygopalatine ganglion)
        ▼
GENICULATE GANGLION (First genu) — Narrowest segment; commonest site of
        │                           compression in Bell's palsy
        ▼
TYMPANIC (HORIZONTAL) SEGMENT
        │
        ▼
SECOND GENU (Pyramidal eminence)
        │
        ▼
MASTOID (VERTICAL) SEGMENT ────► Nerve to Stapedius (at pyramidal eminence)
        │                     ──► Chorda Tympani (5-6 mm above stylomastoid
        │                          foramen → taste anterior 2/3 tongue,
        │                          submandibular/sublingual gland secretion)
        ▼
STYLOMASTOID FORAMEN
        │
        ▼
EXTRATEMPORAL SEGMENT (Parotid plexus)
        │
        ├──► Temporal branch
        ├──► Zygomatic branch
        ├──► Buccal branch
        ├──► Marginal mandibular branch
        └──► Cervical branch

Key Branches (Proximal → Distal):

Branch	Origin	Function
Greater superficial petrosal nerve (GSPN)	Geniculate ganglion (labyrinthine segment)	Lacrimation (via pterygopalatine ganglion)
Nerve to stapedius	Mastoid segment (at pyramidal eminence)	Tensor of stapedius, acoustic reflex
Chorda tympani	Mastoid segment (5-6 mm above stylomastoid foramen)	Taste anterior 2/3 tongue; submandibular + sublingual salivation
Motor branches	Extratemporal, parotid	Facial muscles

3. PRINCIPLES OF TOPODIAGNOSIS

The logic is simple: if a branch is intact, the lesion is distal to its origin; if a branch is absent/impaired, the lesion is at or proximal to its origin.

Hierarchy of branches (Proximal → Distal):

GSPN (lacrimation) → Stapedius nerve (acoustic reflex) → Chorda tympani 
(taste/salivation) → Motor branches (facial movement)

Clinical Rule:

Lesion proximal to GSPN → All functions lost (lacrimation + stapedial reflex + taste + motor)
Lesion between GSPN and stapedius nerve → Lacrimation lost; stapedial reflex + taste + motor lost
Lesion between stapedius nerve and chorda tympani → Lacrimation intact; acoustic reflex lost; taste + motor lost
Lesion between chorda tympani and stylomastoid foramen → Lacrimation + acoustic reflex intact; taste lost; motor lost
Lesion distal to stylomastoid foramen → Only motor lost (all secretomotor and taste intact)

4. INDIVIDUAL TOPODIAGNOSTIC TESTS

4.1 TESTS OF LACRIMAL FUNCTION

A. Schirmer's Lacrimation Test

(Tests the GSPN → assesses function of geniculate ganglion and proximal segments)

Principle: The GSPN carries parasympathetic secretomotor fibres to the lacrimal gland via the pterygopalatine ganglion. Reduced lacrimation on the affected side indicates a lesion at or proximal to the geniculate ganglion.

Technique:

Fold a strip of filter paper (5 mm × 35 mm) at the short end
Place the folded end over the lower eyelid margin at the junction of the medial and middle thirds
Patient keeps eyes open (or closed)
After 5 minutes, measure the length of wetting from the fold

Interpretation:

Wetting (5 min)	Interpretation
> 15 mm	Normal
< 25% of contralateral side	Significant decrease (lesion at/proximal to geniculate ganglion)
< 10 mm on affected side	Strongly abnormal

Clinical significance:

A positive Schirmer's test (reduced lacrimation) places the lesion at or proximal to the geniculate ganglion
Prognostic implication: lesions at this level have poorer prognosis
According to Cummings Otolaryngology: Schirmer's test is best performed within the first 2 weeks of paralysis

Limitations:

Subjective
Affected by ambient temperature, conjunctival irritation, nasal stimulation
False positives in elderly (reduced baseline lacrimation)
Does not distinguish between labyrinthine, IAC, and intracranial segments

Modified Schirmer's test: Uses nasal mucosal stimulation or an ammonia swab to stimulate reflex lacrimation — increases sensitivity.

B. Nasolacrimal Reflex Test

A drop of 10% cocaine or ammonia held near the nostril stimulates the nasal mucosa (via ophthalmic branch of V), and reflex lacrimation via GSPN is assessed. Less commonly used.

4.2 TESTS OF STAPEDIAL REFLEX

Acoustic (Stapedial) Reflex Test

(Tests the nerve to stapedius → assesses function of the mastoid segment at pyramidal eminence)

Principle: Loud sound (70–100 dB above threshold) causes bilateral contraction of the stapedius muscle via: cochlear nerve → cochlear nucleus → superior olivary nucleus → facial nerve motor nucleus → facial nerve → nerve to stapedius.

The nerve to stapedius branches at the level of the pyramidal eminence in the mastoid segment. Absence of the reflex localises the lesion to or proximal to this level.

Technique (Impedance Audiometry/Tympanometry):

A probe is placed in the external ear canal
A loud tone (70–100 dB HL) is delivered to either ear
The resulting change in middle ear compliance (due to stapedius contraction) is measured
Both ipsilateral and contralateral reflexes are recorded

Interpretation:

Reflex Status	Significance
Present	Lesion is distal to pyramidal eminence (below nerve to stapedius origin)
Absent	Lesion is at or proximal to pyramidal eminence

As per Harrison's (p. 1040): "The presence or absence of the acoustic reflex is important in determining the etiology of hearing loss as well as in the anatomic localization of facial nerve paralysis."

Prognostic significance (per Cummings):

Absent stapedial reflex in Bell's palsy within first week → indicates more proximal lesion, poorer prognosis
Stapedial reflex threshold monitoring can track recovery

Note on Recruitment: In cochlear lesions, stapedial reflexes are present or have lower thresholds (recruitment). In retrocochlear/VIII nerve lesions, reflexes decay (abnormal reflex decay test). This distinguishes cochlear from retrocochlear pathology.

4.3 TESTS OF TASTE AND SALIVATION

A. Taste Testing (Gustometry)

(Tests chorda tympani → assesses function of mastoid segment above stylomastoid foramen)

The chorda tympani carries taste fibres from the anterior two-thirds of the tongue and secretomotor fibres to the submandibular and sublingual glands.

Subjective Taste Testing:

Patient's tongue is protruded and dried
Small amounts of four basic taste substances are applied to the anterior two-thirds of each half of the tongue:
- Sweet: 40% sucrose solution
- Sour: 5% citric acid solution
- Salt: 2.5% NaCl solution
- Bitter: 0.5% quinine sulfate solution
Patient indicates which taste they perceive without withdrawing tongue

Interpretation:

Result	Significance
Absent/reduced taste on affected side	Lesion at or proximal to chorda tympani origin
Normal taste	Lesion distal to chorda tympani (between chorda tympani and stylomastoid foramen, or extratemporal)

Limitations:

Highly subjective
Patient cooperation required
Affected by smoking, medications, concurrent illness
Threshold varies significantly between individuals

B. Electrogustometry (EGM)

Principle: An anodal DC current applied to the tongue produces a metallic/acidic taste sensation. The minimum current required (in μA) is the gustatory threshold.

Technique:

An electrode probe is applied to the anterior tongue (lateral surface, anterior 2/3)
A direct current is increased gradually
Threshold at which a taste (usually metallic/sour) is perceived is recorded
Both sides are compared

Interpretation:

Threshold Difference	Significance
< 25 μA	Normal
> 50 μA difference from contralateral	Significant chorda tympani dysfunction
No perception at maximum current	Complete chorda tympani palsy

Advantages over subjective taste testing:

Quantitative
Reproducible
Unaffected by flavor/concentration variability
Can monitor recovery over time

Per Zakir Hussain & Hazarika: EGM is more reliable and reproducible than chemical taste testing and is preferred for clinical topodiagnosis.

C. Submandibular Salivary Flow (Salivary Flow Rate / Saxon Test)

(Tests secretomotor fibres of chorda tympani)

Technique:

Wharton's duct orifices are cannulated bilaterally with fine polyethylene catheters
Salivation is stimulated with 10% citric acid applied to the dorsum of the tongue
Saliva is collected over 5 minutes from both sides
Volume/rate is compared

Interpretation:

Ratio	Significance
Affected side < 25% of contralateral	Significant chorda tympani impairment
Bilaterally reduced	Constitutional, dry mouth

Per Stell & Maran: Submandibular flow rate testing combined with EGM improves localisation accuracy compared to either test alone.

Limitation: Technically demanding, invasive, not widely used in routine practice.

4.4 TESTS OF MOTOR FUNCTION

Motor tests evaluate the degree of degeneration rather than strictly localise the lesion (they cannot distinguish levels within the temporal bone), but they are crucial for prognosis.

A. Nerve Excitability Test (NET) / Hilger's Test

Principle: The facial nerve is stimulated percutaneously at the stylomastoid foramen with an increasing direct current. The minimum current that produces a visible facial twitch is the threshold.

Technique (per Hilger 1964):

A monopolar stimulator electrode is placed over the stylomastoid foramen
Current is gradually increased until the first visible twitch of facial muscles is observed
Both sides are compared

Interpretation:

Threshold Difference	Significance
< 3.5 mA	Normal/non-significant
3.5 mA difference	Suggests significant degeneration
> 3.5–4 mA difference	Denervation likely; poor prognosis
No response at 20 mA on affected side	Complete degeneration

Timing:

NET becomes meaningful after 72 hours (time required for Wallerian degeneration to reach the stylomastoid foramen)
Should be repeated daily or every 2–3 days in acute palsy

Per Dhingra: NET is a simple bedside test but is less precise than electroneurography (ENoG).

Limitation: Subjective endpoint (visual observation), inter-observer variation.

B. Maximal Stimulation Test (MST)

Principle: Modified from NET. Uses a fixed supramaximal current (5 mA) and assesses the degree of movement produced (rather than threshold).

Technique:

Stimulate the nerve at stylomastoid foramen with 5 mA
Compare the amplitude and symmetry of facial movement on both sides

Grading:

Response	Interpretation
Equal bilateral response	Normal
Slightly reduced	Mild degeneration
Markedly reduced	Moderate degeneration
No movement	Complete degeneration

Per Scott-Brown: MST is more sensitive than NET for detecting severe degeneration.

C. Electroneurography (ENoG) / Evoked Electromyography

Considered the gold standard of electrodiagnostic tests for facial nerve prognosis.

Principle: Transcutaneous electrical stimulation of the facial nerve at the stylomastoid foramen generates a compound muscle action potential (CMAP) measured by surface electrodes placed over the nasolabial fold/cheek. The amplitude of the CMAP reflects the number of functional axons.

Technique:

Supramaximal stimulus applied at stylomastoid foramen
CMAP recorded from nasolabial fold/cheek
Peak-to-peak amplitude compared bilaterally

Results expressed as % degeneration:

% Degeneration = [(Normal side CMAP - Affected side CMAP) / Normal side CMAP] × 100

Interpretation:

% Degeneration	Prognosis
< 75%	Excellent recovery expected
75–90%	Good recovery likely
> 90% degeneration	Poor prognosis; surgery may be indicated
100% (flat line)	Complete degeneration

Timing:

ENoG is not useful in first 72 hours (before Wallerian degeneration is complete)
Most informative between days 3–14 of paralysis
After 3 weeks, fibrillation and reinnervation potentials appear on EMG

Per Cummings Otolaryngology: ENoG showing >90% degeneration within 14 days of onset in Bell's palsy is an indication for surgical decompression (controversial).

Per Harrison's Principles (p. 1040): Electrodiagnostic testing is important for prognosis; absent responses predict poor recovery.

Advantages:

Quantitative
Reproducible
Objective
Tracks progression and recovery

Limitations:

Requires 72-hour delay
Painful
Requires specialist equipment
Not valid after 3 weeks (fibrillation confounds results)

D. Electromyography (EMG)

Principle: Fine needle electrodes are inserted into facial muscles to record motor unit action potentials (MUAPs) at rest and during voluntary contraction.

Technique:

Needle electrode inserted into orbicularis oculi, orbicularis oris, frontalis
Spontaneous activity recorded at rest
Voluntary activity recorded during attempted movement

EMG Patterns and Interpretation:

EMG Finding	Timing	Significance
Normal MUAPs with reduced recruitment	Acute (days 1–3)	Neuropraxia; good prognosis
Electrical silence	Days 1–3	Axonotmesis/neurotmesis
Fibrillation potentials	After 2–3 weeks	Wallerian degeneration complete; denervation
Positive sharp waves	After 2–3 weeks	Active denervation
Polyphasic potentials	Weeks to months	Reinnervation beginning
Normal MUAPs returning	Months	Recovery

Clinical relevance:

EMG is the only test that can confirm reinnervation before clinical recovery is visible — polyphasic potentials appear weeks before visible movement
This helps prevent premature surgical intervention

Per Zakir Hussain: The presence of voluntary MUAPs even in minimal amounts indicates incomplete degeneration and predicts recovery without surgery.

E. Nerve Conduction Study (NCS) — Antidromic Stimulation

Measures latency and amplitude of CMAP from stimulation at the stylomastoid foramen to recording at the facial muscles. Not commonly used in isolation for topodiagnosis but complements ENoG.

4.5 TESTS OF SALIVARY FUNCTION (Summary)

Test	Branch Tested	Level Localised
Submandibular flow rate	Chorda tympani	Mastoid segment, above stylomastoid foramen
Electrogustometry	Chorda tympani (taste)	Mastoid segment
Schirmer's test	GSPN	Geniculate ganglion/labyrinthine segment

5. TOPODIAGNOSTIC FLOW CHARTS

FLOWCHART 1: Level of Lesion Based on Clinical Tests

┌─────────────────────────────────────────────────────┐
│           FACIAL NERVE PALSY DETECTED                │
└──────────────────────┬──────────────────────────────┘
                       │
                       ▼
          ┌────────────────────────┐
          │  TEST 1: SCHIRMER'S   │
          │  (Lacrimation test)   │
          └────────────┬───────────┘
                       │
          ┌────────────┴────────────┐
          │                         │
      REDUCED                    NORMAL
          │                         │
          ▼                         ▼
  Lesion at/proximal          Lesion DISTAL to
  to GENICULATE               geniculate ganglion
  GANGLION                         │
  (Labyrinthine,                    ▼
   IAC, or CPA)          ┌──────────────────────┐
                         │  TEST 2: ACOUSTIC    │
                         │  REFLEX (Impedance)  │
                         └──────────┬───────────┘
                                    │
                         ┌──────────┴──────────┐
                         │                      │
                      ABSENT                  PRESENT
                         │                      │
                         ▼                      ▼
              Lesion at/proximal      Lesion DISTAL to
              to PYRAMIDAL            pyramidal eminence
              EMINENCE (nerve                   │
              to stapedius level)               ▼
                              ┌─────────────────────────────┐
                              │  TEST 3: ELECTROGUSTOMETRY  │
                              │  / TASTE TESTING            │
                              └──────────────┬──────────────┘
                                             │
                              ┌──────────────┴──────────────┐
                              │                              │
                           ABSENT                         PRESENT
                              │                              │
                              ▼                              ▼
                   Lesion at/proximal             Lesion between CHORDA
                   to CHORDA TYMPANI              TYMPANI origin and
                   origin (vertical/              STYLOMASTOID FORAMEN
                   mastoid segment)                         │
                                                            ▼
                                               ┌───────────────────────┐
                                               │ Lesion DISTAL to      │
                                               │ stylomastoid foramen  │
                                               │ (EXTRATEMPORAL)       │
                                               └───────────────────────┘

FLOWCHART 2: Summary of Level-Based Functional Losses

LEVEL OF LESION          | GSPN | STAPEDIUS | CHORDA TYMPANI | MOTOR
─────────────────────────┼──────┼───────────┼────────────────┼───────
CPA / IAC / Labyrinthine │  ✗   │     ✗     │       ✗        │   ✗
─────────────────────────┼──────┼───────────┼────────────────┼───────
Geniculate ganglion      │  ✗   │     ✗     │       ✗        │   ✗
─────────────────────────┼──────┼───────────┼────────────────┼───────
Tympanic segment         │  ✓   │     ✗     │       ✗        │   ✗
─────────────────────────┼──────┼───────────┼────────────────┼───────
Mastoid seg. (above      │  ✓   │     ✓     │       ✗        │   ✗
chorda tympani)          │      │           │                │
─────────────────────────┼──────┼───────────┼────────────────┼───────
Mastoid seg. (below      │  ✓   │     ✓     │       ✓        │   ✗
chorda tympani /         │      │           │                │
stylomastoid foramen)    │      │           │                │
─────────────────────────┼──────┼───────────┼────────────────┼───────
Extratemporal /          │  ✓   │     ✓     │       ✓        │   ✗
Parotid                  │      │           │                │

✗ = Abnormal/absent    ✓ = Intact/normal

FLOWCHART 3: Electrodiagnostic Tests in Acute Facial Palsy

ACUTE FACIAL PALSY (Complete paralysis)
            │
            ▼
   First 72 hours
            │
   ┌────────────────────────┐
   │  CLINICAL GRADING      │
   │  (House-Brackmann)     │
   └───────────┬────────────┘
               │
               ▼
      After 72 hours (Day 3)
               │
   ┌───────────────────────────────┐
   │  ELECTRONEUROGRAPHY (ENoG)    │
   │  + NET / MST                  │
   └───────────────┬───────────────┘
                   │
      ┌────────────┴────────────┐
      │                         │
   < 90%                     ≥ 90%
   Degeneration              Degeneration
      │                         │
      ▼                         ▼
Conservative               ┌─────────────────────┐
management                 │   EMG to confirm     │
(steroids,                 │   active denervation │
antivirals)                └──────────┬──────────┘
                                      │
                           ┌──────────┴──────────┐
                           │                      │
                     Denervation +            No voluntary
                     NO voluntary             MUAPs → Consider
                     MUAPs                   SURGICAL
                                             DECOMPRESSION

6. CLINICAL CORRELATION: LESION LEVELS AND DISEASES

Level of Lesion	Topodiagnostic Pattern	Common Causes
Cerebellopontine angle (CPA)	All functions lost + ipsilateral sensorineural hearing loss + V, VI, VIII nerve involvement	Acoustic neuroma, meningioma, epidermoid cyst
Internal acoustic canal (IAC)	All functions lost + sensorineural hearing loss + vertigo	Acoustic neuroma, Bell's palsy (occasionally), trauma
Geniculate ganglion / Labyrinthine segment	All functions lost; vesicles in EAC (Ramsay Hunt syndrome)	Herpes zoster oticus (Ramsay Hunt), Bell's palsy, trauma
Tympanic segment	Stapedial reflex + taste + motor lost; lacrimation intact	Cholesteatoma, trauma, otitis media
Mastoid segment (above chorda tympani)	Taste + motor lost; stapedial reflex + lacrimation intact	Mastoiditis, cholesteatoma
At/below chorda tympani	Motor lost only (taste, lacrimation, stapedial reflex intact)	Trauma, surgical injury, Bell's palsy (mild)
Stylomastoid foramen / Extratemporal	Pure motor palsy; all secretomotor intact	Parotid tumours, trauma, forceps delivery

7. HOUSE-BRACKMANN GRADING SYSTEM (Motor Assessment)

Used alongside topodiagnostic tests to quantify the degree of motor loss.

Grade	Description	Characteristics
I	Normal	Normal function
II	Mild dysfunction	Slight weakness; complete eye closure; slight asymmetry
III	Moderate dysfunction	Obvious asymmetry; complete eye closure with effort; moderate to good forehead movement
IV	Moderately severe	Obvious weakness; incomplete eye closure; no forehead movement
V	Severe dysfunction	Barely perceptible motion; incomplete eye closure; no forehead movement
VI	Total paralysis	No movement

8. IMAGING IN TOPODIAGNOSIS

While clinical topodiagnostic tests narrow down the level of the lesion, imaging confirms the etiology.

MRI with Gadolinium:

T1 post-contrast shows enhancement of the facial nerve at the site of pathology
In Bell's palsy: Enhancement at the geniculate ganglion / labyrinthine segment (as illustrated in the retrieved MRI image — enhancement at geniculate ganglion in T1 post-contrast axial and coronal views)
In acoustic neuroma: Enhancing mass in IAC
MRI differentiates inflammatory from neoplastic causes by the pattern of enhancement (nodular vs. linear)

HRCT Temporal Bone:

Fracture lines in trauma
Cholesteatoma eroding fallopian canal
Bony dehiscence of facial canal

Bell's Palsy MRI showing enhancement at geniculate ganglion

MRI T1 post-gadolinium showing linear enhancement of the facial nerve at the geniculate ganglion (arrow) in Bell's palsy — typical finding of inflammatory neuropathy

9. RECENT ADVANCES

9.1 MRI Neurography

High-resolution 3D MRI sequences (FIESTA, CISS, VIBE) allow in vivo visualisation of the full intratemporal facial nerve course
Can detect perineural spread of parotid malignancy
Functional MRI tractography beginning to map central facial nerve pathways

9.2 Three-Dimensional ENoG (3D-ENoG)

Uses multiple recording electrodes to map individual branch contributions to CMAP
Greater sensitivity for partial degeneration

9.3 High-Frequency Ultrasound

Real-time imaging of extratemporal facial nerve branches
Non-invasive, dynamic assessment of nerve diameter and cross-sectional area
Useful in parotid surgery planning
Recent meta-analyses show sensitivity ~80% for detecting facial nerve pathology extracranially

9.4 Optical Coherence Tomography (OCT)

Emerging research tool for intraoperative facial nerve identification
Not yet in routine clinical use

9.5 Transcranial Magnetic Stimulation (TMS) — Central Topodiagnosis

Differentiates upper motor neuron (UMN) from lower motor neuron (LMN) facial palsy
Magnetic stimulation over motor cortex evokes CMAPs from facial muscles
Present in UMN lesion (Bell's phenomenon intact); absent in complete LMN

9.6 Salivary Biomarkers

Research on salivary cytokines (IL-6, TNF-α) as proxies for chorda tympani activity and inflammatory grade
Not yet in clinical use

9.7 Near-Infrared Spectroscopy (NIRS)

Experimental modality for intraoperative nerve identification during mastoid surgery

10. LIMITATIONS AND PRACTICAL PITFALLS OF TOPODIAGNOSTIC TESTS

Test	Limitation
Schirmer's test	Age-related reduction; conjunctival irritation affects result
Acoustic reflex	Absent in concurrent middle ear disease; not interpretable with conductive hearing loss
Taste testing	Subjective; poor reliability
EGM	Habitual smokers have elevated thresholds
ENoG	Not valid before 72 hours or after 3 weeks
EMG	Requires skilled neurophysiologist; painful
NET	Subjective endpoint; ±3.5 mA threshold empirical

Per Scott-Brown: No single test is sufficient; a battery of tests should always be used for reliable topodiagnosis.

11. PRACTICAL APPROACH: ALGORITHM FOR A PATIENT WITH ACUTE COMPLETE FACIAL PALSY

HISTORY + EXAMINATION
        │
        ├── UMN features? → Forehead sparing → MRI brain (CVA/tumor)
        │
        └── LMN features (complete unilateral palsy with forehead)
                │
                ▼
          TOPODIAGNOSTIC BATTERY:
          ① Schirmer's test (lacrimation)
          ② Acoustic reflex (impedance audiometry)
          ③ Taste testing / EGM
          ④ House-Brackmann grading
                │
                ▼
          Level of lesion localised
                │
                ├── CPA/IAC suspected → MRI with gadolinium
                ├── Tympanic/mastoid → HRCT temporal bone + MRI
                └── Extratemporal → Parotid imaging (USG/MRI)
                │
                ▼
          ELECTRODIAGNOSTIC TESTING (after 72 hours):
          ENoG + EMG
                │
          ├── <90% degeneration → Medical treatment
          └── ≥90% degeneration + absence of MUAPs → Consider surgical decompression

12. SUMMARY TABLE: ALL TOPODIAGNOSTIC TESTS AT A GLANCE

Test	Branch Tested	Level Localised	Modality	Gold Standard?
Schirmer's test	GSPN	Geniculate ganglion/proximal	Clinical	No
Acoustic reflex	Nerve to stapedius	Pyramidal eminence (mastoid)	Impedance audiometry	No
Taste testing	Chorda tympani (taste)	Mastoid (above stylomastoid)	Clinical/Chemical	No
Electrogustometry	Chorda tympani (taste)	Mastoid (above stylomastoid)	Electrophysiological	Preferred for taste
Salivary flow	Chorda tympani (secretomotor)	Mastoid	Clinical	No
NET (Hilger's)	Motor (whole nerve)	Prognosis	Electrical stimulation	No
MST	Motor (whole nerve)	Prognosis	Electrical stimulation	No
ENoG	Motor (whole nerve)	Prognosis + degeneration %	Electrophysiological	Yes (prognostic)
EMG	Motor unit level	Reinnervation	Electrophysiological	Yes (reinnervation)
MRI gadolinium	Anatomical	All levels	Imaging	Yes (etiology)
HRCT temporal bone	Bony canal	All intratemporal levels	Imaging	Yes (bony pathology)

CONCLUSION

Topodiagnosis of facial nerve lesions requires a systematic, stepwise approach using a battery of tests. The classical hierarchy proceeds from:

Lacrimation (Schirmer's) → Acoustic Reflex → Taste/Salivation (EGM) → Motor (ENoG/EMG)

This progression mirrors the proximal-to-distal branching of the nerve and allows precise anatomical localisation. Electrodiagnostic tests (especially ENoG and EMG) are critical for prognostication and surgical decision-making rather than pure localisation.

With modern MRI neurography and high-frequency ultrasound, the accuracy of topodiagnosis has improved significantly, allowing both anatomical localisation and etiological diagnosis to be achieved non-invasively.

"No single test is pathognomonic. The clinician must correlate all findings with clinical history and examination." — Scott-Brown's Otorhinolaryngology, 8th Edition

Key References:

Scott-Brown's Otorhinolaryngology Head & Neck Surgery, 8th Ed.
Cummings Otolaryngology Head & Neck Surgery, 7th Ed.
Stell & Maran's Head and Neck Surgery, 4th Ed.
Zakir Hussain's ENT for Postgraduates
Dhingra's Diseases of Ear, Nose and Throat, 7th Ed.
Hazarika's Textbook of Ear Nose Throat and Head & Neck Surgery
Harrison's Principles of Internal Medicine, 21st Ed. (pp. 1040, 12500)
House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985
Fisch U. Surgery for Bell's palsy. Arch Otolaryngol. 1981
Gantz BJ et al. Surgical management of Bell's palsy. Laryngoscope. 1999

This is a shared conversation. Sign in to Orris to start your own chat.